GjessingJ.Addition of aminoacids to peritoneal-dialysis fluid.Lancet1968; 2: 812.
2.
WilliamsP.F., MarlissE.B., AndersonG.H., OrenA., SteinA., KhannaR.Amino acid absorption following intraperitoneal administration in CAPD patients.Perit Dial Bull1982; 2: 124–9.
3.
OrenA., WuG., AndersonG.H., MarlissE., KhannaR., PettitJ.Effective use of amino acid dialysate over four weeks in CAPD patients.Perit Dial Bull1983; 3: 66–73.
4.
PedersenF.B., DragsholtC., LaierE., FrifeltJ.J., TrostmannA.F., EkelundS.Alternate use of amino acid and glucose solutions in CAPD.Perit Dial Bull1985; 5: 215–18.
5.
ArleenS., GoodshipT.H.J., KirkwoodA., WardM.K.The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.Clin Nephrol1990; 33: 192–9.
6.
YoungG.A., DibbleJ.B., HobsonS.M., TompkinsL., GibsonJ., TurneyJ.H.The use of an amino-acid-based CAPD fluid over 12 weeks.Nephrol Dial Transplant1989; 4: 285–92.
7.
BrunoM., BagnisC., MarangellaM., RoveraL., CantaluppiA., LinariF.CAPD with an amino acid dialysis solution: a long-term, cross-over study.Kidney Int1989; 35: 1189–94.
8.
CanepaA., PerfumoF., CarreaA., GiallongoF., VerrinaE., CantaluppiA.Long-term effect of amino-acid dialysis solution in children on continuous ambulatory peritoneal dialysis.Pediatr Nephrol1991; 5: 215–19.
9.
RenzoS., BeatriceD., GiuseppeI.CAPD in diabetics: use of amino acids.Adv Perit Dial1990; 6: 53–5.
10.
JonesM.R., MartisL., AlgrimC.E., BernardD., SwartzR., MessanaJ.Amino acid solutions for CAPD: rationale and clinical experience.Miner Electrolyte Metab1992; 18: 309–15.
11.
KoppleJ.D., BernardD., MessanaJ., SwartzR., BergstromJ., LindholmB.Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int1995; 47: 1148–57.
12.
FallerB., AparicioM., FaictD., De VosC., de PrecigoutV., LarroumetN.Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis.Nephrol Dial Transplant1995; 10: 1432–7.
13.
OlszowskaA., WaniewskiJ., WerynskiA., AnderstamB., LindholmB., WankowiczZ.Peritoneal transport in peritoneal dialysis patients using glucose-based and amino acid-based solutions.Perit Dial Int2007; 27: 544–53.
14.
GoodshipT.H., LloydS., McKenzieP.W., EarnshawM., SmeatonI., BartlettK.Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis.Clin Sci (Lond)1987; 73: 471–8.
15.
LindholmB., WerynskiA., BergstromJ.Peritoneal dialysis with amino acid solutions: fluid and solute transport kinetics.Artif Organs1988; 12: 2–10.
16.
WaniewskiJ., WerynskiA., HeimbürgerO., ParkM.S., LindholmB.Effect of alternative osmotic agents on peritoneal transport.Blood Purif1993; 11: 248–64.
17.
ParkM.S., HeimbürgerO., BergstromJ., WaniewskiJ., WerynskiA., LindholmB.Peritoneal transport during dialysis with amino acid-based solutions.Perit Dial Int1993; 13: 280–8.
18.
YoungG.A., DibbleJ.B., TaylorA.E., KendallS., BrownjohnA.M.A longitudinal study of the effects of amino acid-based CAPD fluid on amino acid retention and protein losses.Nephrol Dial Transplant1989; 4: 900–5.
19.
SteinhauerH.B., Lubrich-BirknerI., KlutheR., BaumannG., SchollmeyerP.Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.Am J Nephrol1992; 12: 61–7.
20.
DoumaC.E., de WaartD.R., StruijkD.G., KredietR.T.Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?Clin Nephrol1996; 45: 295–302.
21.
MartikainenT.A., TeppoA.M., Gronhagen-RiskaC., EkstrandA.V.Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?Perit Dial Int2005; 25: 453–60.
22.
WaniewskiJ., HeimbürgerO., WerynskiA., LindholmB.Diffusive mass transport coefficients are not constant during a single exchange in continuous ambulatory peritoneal dialysis.ASAIO J1996; 42: M518–23.
23.
NakaoT., OguraM., TakahashiH., OkadaT.Charge-affected transperitoneal movement of amino acids in CAPD.Perit Dial Int1996; 16(Suppl 1): S88–90.
24.
RippeB., StelinG.Simulations of peritoneal solute transport during continuous ambulatory peritoneal dialysis (CAPD). Application of two-pore formalism.Kidney Int1989; 35: 1234–44.
25.
RippeB., StelinG., HaraldssonB.Computer simulations of peritoneal fluid transport in CAPD.Kidney Int1991; 40: 315–25.
26.
RippeB., LevinL.Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.Kidney Int2000; 57: 2546–56.
27.
RippeB., KredietR.T.Peritoneal physiology. Transport of solutes. In: The Textbook of Peritoneal Dialysis.GokalR.C., NolphK.D., eds. Dordrecht: Kluwer Academic; 1994: 68–132.
28.
KredietR.T., KoomenG.C., KoopmanM.G., HoekF.J., StruijkD.G., BoeschotenE.W.The peritoneal transport of serum proteins and neutral dextran in CAPD patients.Kidney Int1989; 35: 1064–72.
